Stingl John, Caldas Carlos
Department of Pathology, University of Cambridge, Tennis Court Road, Cambridge CB2 1QP, UK.
Nat Rev Cancer. 2007 Oct;7(10):791-9. doi: 10.1038/nrc2212.
Human breast cancers are heterogeneous, both in their pathology and in their molecular profiles. This suggests the hypothesis that breast cancers can initiate in different cell types, either breast epithelial stem cells or their progeny (transit amplifying cells or committed differentiated cells). In this respect, breast cancer could be viewed as being similar to haematological malignancies for which an analogous model has been proposed. Drawing such parallels might help to unravel the molecular nature of the initiating events in breast cancer and might have substantial clinical implications.
人类乳腺癌在病理和分子特征方面都是异质性的。这提示了一种假说,即乳腺癌可能起源于不同的细胞类型,要么是乳腺上皮干细胞,要么是它们的子代(过渡增殖细胞或定向分化细胞)。在这方面,乳腺癌可被视为类似于已提出类似模型的血液系统恶性肿瘤。进行这样的类比可能有助于揭示乳腺癌起始事件的分子本质,并且可能具有重大的临床意义。